Anti-aging, anti-inflammatory, moisturizing, soothing … so many cosmetic claims to be assessed from the first stages of an innovative cosmetic. The choice of efficacy tests is often too large and complex to quickly and inexpensively define the effect of a new active compound on the skin biology. StratiCELL offers to accelerate your innovation by coupling a transcriptomic screening to a proprietary database containing more than 3,500 genes organized by skin biology topics. This powerful analysis tool known as the StratiCELL Skin Knowledge Database (SSKDB) will accelerate the understanding of the mechanism of action of any new ingredient. Cosmetic objectivation is fast and focused, and total product launch time is reduced.
Read more about the SSKDB on http://StratiCELL.com/dna-microarray
Discover the full panel of in vitro efficacy testing by StratiCELL on https://StratiCELL.com
Contact the experts at info@StratiCELL.com
In the dynamic landscape of dermatology research and development, Clinical Research Organizations (CROs) play a…
Explore Trends and Innovations at NYSCC To register, click here 📅 on Tuesday May…
Roger Guillemin identified the molecules in the brain that control the production of hormones in…
